CVE-2010-5035

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in search.php in iScripts eSwap 2.0 allows remote attackers to inject arbitrary web script or HTML via the txtHomeSearch parameter (aka the search field). NOTE: some of these details are obtained from third party information.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 6.31% Top 10%
Vendor Advisory secunia.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/59148 vdb entry
http://packetstormsecurity.org/1006-exploits/iscriptsewap-sqlxss.txt exploit
http://www.vupen.com/english/advisories/2010/1360 vdb entry vendor advisory
http://securityreason.com/securityalert/8522 third party advisory
http://www.securityfocus.com/bid/40597 vdb entry exploit
http://secunia.com/advisories/40087 third party advisory vendor advisory
http://www.exploit-db.com/exploits/13740/ exploit

Frequently Asked Questions

What is the severity of CVE-2010-5035?
CVE-2010-5035 has been scored as a medium severity vulnerability.
How to fix CVE-2010-5035?
To fix CVE-2010-5035, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-5035 being actively exploited in the wild?
It is possible that CVE-2010-5035 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~6% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.